Global Paclitaxel Market Research Report 2023

Publisher Name :
Date: 04-Jan-2023
No. of pages: 93
Inquire Before Buying

This report aims to provide a comprehensive presentation of the global market for Paclitaxel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel.

The Paclitaxel market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Paclitaxel market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Paclitaxel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Phyton

- ScinoPharm

- Novasep

- Samyang

- Polymed

- TAPI (Teva)

- Fresenius-kabi

- Huiang biopharma

- Southpharma

- Yunnan Hande

- Hainan Yew Pharm

- Jiangsu Yew Biotechnology

Segment by Type

- Natural Paclitaxel API

- Semi-synthetic Paclitaxel API

Segment by Application

- Ovarian Cancer

- Cervical Cancer

- Breast Cancer

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Paclitaxel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Paclitaxel Market Research Report 2023

Table of Contents
1 Paclitaxel Market Overview
1.1 Product Overview and Scope of Paclitaxel
1.2 Paclitaxel Segment by Type
1.2.1 Global Paclitaxel Market Value Comparison by Type (2023-2029)
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Paclitaxel Segment by Application
1.3.1 Global Paclitaxel Market Value by Application: (2023-2029)
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Global Paclitaxel Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel Revenue 2018-2029
1.4.2 Global Paclitaxel Sales 2018-2029
1.4.3 Global Paclitaxel Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Paclitaxel Market Competition by Manufacturers
2.1 Global Paclitaxel Sales Market Share by Manufacturers (2018-2023)
2.2 Global Paclitaxel Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Paclitaxel Average Price by Manufacturers (2018-2023)
2.4 Global Paclitaxel Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Paclitaxel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel, Product Type & Application
2.7 Paclitaxel Market Competitive Situation and Trends
2.7.1 Paclitaxel Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paclitaxel Players Market Share by Revenue
2.7.3 Global Paclitaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paclitaxel Retrospective Market Scenario by Region
3.1 Global Paclitaxel Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Paclitaxel Global Paclitaxel Sales by Region: 2018-2029
3.2.1 Global Paclitaxel Sales by Region: 2018-2023
3.2.2 Global Paclitaxel Sales by Region: 2024-2029
3.3 Global Paclitaxel Global Paclitaxel Revenue by Region: 2018-2029
3.3.1 Global Paclitaxel Revenue by Region: 2018-2023
3.3.2 Global Paclitaxel Revenue by Region: 2024-2029
3.4 North America Paclitaxel Market Facts & Figures by Country
3.4.1 North America Paclitaxel Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Paclitaxel Sales by Country (2018-2029)
3.4.3 North America Paclitaxel Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Paclitaxel Market Facts & Figures by Country
3.5.1 Europe Paclitaxel Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Paclitaxel Sales by Country (2018-2029)
3.5.3 Europe Paclitaxel Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel Market Facts & Figures by Country
3.6.1 Asia Pacific Paclitaxel Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Paclitaxel Sales by Country (2018-2029)
3.6.3 Asia Pacific Paclitaxel Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Paclitaxel Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Paclitaxel Sales by Country (2018-2029)
3.7.3 Latin America Paclitaxel Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Paclitaxel Sales by Country (2018-2029)
3.8.3 Middle East and Africa Paclitaxel Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Paclitaxel Sales by Type (2018-2029)
4.1.1 Global Paclitaxel Sales by Type (2018-2023)
4.1.2 Global Paclitaxel Sales by Type (2024-2029)
4.1.3 Global Paclitaxel Sales Market Share by Type (2018-2029)
4.2 Global Paclitaxel Revenue by Type (2018-2029)
4.2.1 Global Paclitaxel Revenue by Type (2018-2023)
4.2.2 Global Paclitaxel Revenue by Type (2024-2029)
4.2.3 Global Paclitaxel Revenue Market Share by Type (2018-2029)
4.3 Global Paclitaxel Price by Type (2018-2029)
5 Segment by Application
5.1 Global Paclitaxel Sales by Application (2018-2029)
5.1.1 Global Paclitaxel Sales by Application (2018-2023)
5.1.2 Global Paclitaxel Sales by Application (2024-2029)
5.1.3 Global Paclitaxel Sales Market Share by Application (2018-2029)
5.2 Global Paclitaxel Revenue by Application (2018-2029)
5.2.1 Global Paclitaxel Revenue by Application (2018-2023)
5.2.2 Global Paclitaxel Revenue by Application (2024-2029)
5.2.3 Global Paclitaxel Revenue Market Share by Application (2018-2029)
5.3 Global Paclitaxel Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Phyton
6.1.1 Phyton Corporation Information
6.1.2 Phyton Description and Business Overview
6.1.3 Phyton Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Phyton Paclitaxel Product Portfolio
6.1.5 Phyton Recent Developments/Updates
6.2 ScinoPharm
6.2.1 ScinoPharm Corporation Information
6.2.2 ScinoPharm Description and Business Overview
6.2.3 ScinoPharm Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.2.4 ScinoPharm Paclitaxel Product Portfolio
6.2.5 ScinoPharm Recent Developments/Updates
6.3 Novasep
6.3.1 Novasep Corporation Information
6.3.2 Novasep Description and Business Overview
6.3.3 Novasep Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novasep Paclitaxel Product Portfolio
6.3.5 Novasep Recent Developments/Updates
6.4 Samyang
6.4.1 Samyang Corporation Information
6.4.2 Samyang Description and Business Overview
6.4.3 Samyang Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Samyang Paclitaxel Product Portfolio
6.4.5 Samyang Recent Developments/Updates
6.5 Polymed
6.5.1 Polymed Corporation Information
6.5.2 Polymed Description and Business Overview
6.5.3 Polymed Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Polymed Paclitaxel Product Portfolio
6.5.5 Polymed Recent Developments/Updates
6.6 TAPI (Teva)
6.6.1 TAPI (Teva) Corporation Information
6.6.2 TAPI (Teva) Description and Business Overview
6.6.3 TAPI (Teva) Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.6.4 TAPI (Teva) Paclitaxel Product Portfolio
6.6.5 TAPI (Teva) Recent Developments/Updates
6.7 Fresenius-kabi
6.6.1 Fresenius-kabi Corporation Information
6.6.2 Fresenius-kabi Description and Business Overview
6.6.3 Fresenius-kabi Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fresenius-kabi Paclitaxel Product Portfolio
6.7.5 Fresenius-kabi Recent Developments/Updates
6.8 Huiang biopharma
6.8.1 Huiang biopharma Corporation Information
6.8.2 Huiang biopharma Description and Business Overview
6.8.3 Huiang biopharma Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Huiang biopharma Paclitaxel Product Portfolio
6.8.5 Huiang biopharma Recent Developments/Updates
6.9 Southpharma
6.9.1 Southpharma Corporation Information
6.9.2 Southpharma Description and Business Overview
6.9.3 Southpharma Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Southpharma Paclitaxel Product Portfolio
6.9.5 Southpharma Recent Developments/Updates
6.10 Yunnan Hande
6.10.1 Yunnan Hande Corporation Information
6.10.2 Yunnan Hande Description and Business Overview
6.10.3 Yunnan Hande Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Yunnan Hande Paclitaxel Product Portfolio
6.10.5 Yunnan Hande Recent Developments/Updates
6.11 Hainan Yew Pharm
6.11.1 Hainan Yew Pharm Corporation Information
6.11.2 Hainan Yew Pharm Paclitaxel Description and Business Overview
6.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hainan Yew Pharm Paclitaxel Product Portfolio
6.11.5 Hainan Yew Pharm Recent Developments/Updates
6.12 Jiangsu Yew Biotechnology
6.12.1 Jiangsu Yew Biotechnology Corporation Information
6.12.2 Jiangsu Yew Biotechnology Paclitaxel Description and Business Overview
6.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Jiangsu Yew Biotechnology Paclitaxel Product Portfolio
6.12.5 Jiangsu Yew Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel Industry Chain Analysis
7.2 Paclitaxel Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel Production Mode & Process
7.4 Paclitaxel Sales and Marketing
7.4.1 Paclitaxel Sales Channels
7.4.2 Paclitaxel Distributors
7.5 Paclitaxel Customers
8 Paclitaxel Market Dynamics
8.1 Paclitaxel Industry Trends
8.2 Paclitaxel Market Drivers
8.3 Paclitaxel Market Challenges
8.4 Paclitaxel Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Paclitaxel Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Paclitaxel Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Paclitaxel Market Competitive Situation by Manufacturers in 2022
Table 4. Global Paclitaxel Sales (Kg) of Key Manufacturers (2018-2023)
Table 5. Global Paclitaxel Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Paclitaxel Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Paclitaxel Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Paclitaxel Average Price (USD/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Paclitaxel, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Paclitaxel, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Paclitaxel, Product Type & Application
Table 12. Global Key Manufacturers of Paclitaxel, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Paclitaxel by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Paclitaxel Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Paclitaxel Sales by Region (2018-2023) & (Kg)
Table 18. Global Paclitaxel Sales Market Share by Region (2018-2023)
Table 19. Global Paclitaxel Sales by Region (2024-2029) & (Kg)
Table 20. Global Paclitaxel Sales Market Share by Region (2024-2029)
Table 21. Global Paclitaxel Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Paclitaxel Revenue Market Share by Region (2018-2023)
Table 23. Global Paclitaxel Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Paclitaxel Revenue Market Share by Region (2024-2029)
Table 25. North America Paclitaxel Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Paclitaxel Sales by Country (2018-2023) & (Kg)
Table 27. North America Paclitaxel Sales by Country (2024-2029) & (Kg)
Table 28. North America Paclitaxel Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Paclitaxel Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Paclitaxel Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Paclitaxel Sales by Country (2018-2023) & (Kg)
Table 32. Europe Paclitaxel Sales by Country (2024-2029) & (Kg)
Table 33. Europe Paclitaxel Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Paclitaxel Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Paclitaxel Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Paclitaxel Sales by Region (2018-2023) & (Kg)
Table 37. Asia Pacific Paclitaxel Sales by Region (2024-2029) & (Kg)
Table 38. Asia Pacific Paclitaxel Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Paclitaxel Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Paclitaxel Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Paclitaxel Sales by Country (2018-2023) & (Kg)
Table 42. Latin America Paclitaxel Sales by Country (2024-2029) & (Kg)
Table 43. Latin America Paclitaxel Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Paclitaxel Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Paclitaxel Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Paclitaxel Sales by Country (2018-2023) & (Kg)
Table 47. Middle East & Africa Paclitaxel Sales by Country (2024-2029) & (Kg)
Table 48. Middle East & Africa Paclitaxel Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Paclitaxel Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Paclitaxel Sales (Kg) by Type (2018-2023)
Table 51. Global Paclitaxel Sales (Kg) by Type (2024-2029)
Table 52. Global Paclitaxel Sales Market Share by Type (2018-2023)
Table 53. Global Paclitaxel Sales Market Share by Type (2024-2029)
Table 54. Global Paclitaxel Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Paclitaxel Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Paclitaxel Revenue Market Share by Type (2018-2023)
Table 57. Global Paclitaxel Revenue Market Share by Type (2024-2029)
Table 58. Global Paclitaxel Price (USD/Kg) by Type (2018-2023)
Table 59. Global Paclitaxel Price (USD/Kg) by Type (2024-2029)
Table 60. Global Paclitaxel Sales (Kg) by Application (2018-2023)
Table 61. Global Paclitaxel Sales (Kg) by Application (2024-2029)
Table 62. Global Paclitaxel Sales Market Share by Application (2018-2023)
Table 63. Global Paclitaxel Sales Market Share by Application (2024-2029)
Table 64. Global Paclitaxel Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Paclitaxel Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Paclitaxel Revenue Market Share by Application (2018-2023)
Table 67. Global Paclitaxel Revenue Market Share by Application (2024-2029)
Table 68. Global Paclitaxel Price (USD/Kg) by Application (2018-2023)
Table 69. Global Paclitaxel Price (USD/Kg) by Application (2024-2029)
Table 70. Phyton Corporation Information
Table 71. Phyton Description and Business Overview
Table 72. Phyton Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 73. Phyton Paclitaxel Product
Table 74. Phyton Recent Developments/Updates
Table 75. ScinoPharm Corporation Information
Table 76. ScinoPharm Description and Business Overview
Table 77. ScinoPharm Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 78. ScinoPharm Paclitaxel Product
Table 79. ScinoPharm Recent Developments/Updates
Table 80. Novasep Corporation Information
Table 81. Novasep Description and Business Overview
Table 82. Novasep Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 83. Novasep Paclitaxel Product
Table 84. Novasep Recent Developments/Updates
Table 85. Samyang Corporation Information
Table 86. Samyang Description and Business Overview
Table 87. Samyang Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 88. Samyang Paclitaxel Product
Table 89. Samyang Recent Developments/Updates
Table 90. Polymed Corporation Information
Table 91. Polymed Description and Business Overview
Table 92. Polymed Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 93. Polymed Paclitaxel Product
Table 94. Polymed Recent Developments/Updates
Table 95. TAPI (Teva) Corporation Information
Table 96. TAPI (Teva) Description and Business Overview
Table 97. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 98. TAPI (Teva) Paclitaxel Product
Table 99. TAPI (Teva) Recent Developments/Updates
Table 100. Fresenius-kabi Corporation Information
Table 101. Fresenius-kabi Description and Business Overview
Table 102. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 103. Fresenius-kabi Paclitaxel Product
Table 104. Fresenius-kabi Recent Developments/Updates
Table 105. Huiang biopharma Corporation Information
Table 106. Huiang biopharma Description and Business Overview
Table 107. Huiang biopharma Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 108. Huiang biopharma Paclitaxel Product
Table 109. Huiang biopharma Recent Developments/Updates
Table 110. Southpharma Corporation Information
Table 111. Southpharma Description and Business Overview
Table 112. Southpharma Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 113. Southpharma Paclitaxel Product
Table 114. Southpharma Recent Developments/Updates
Table 115. Yunnan Hande Corporation Information
Table 116. Yunnan Hande Description and Business Overview
Table 117. Yunnan Hande Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 118. Yunnan Hande Paclitaxel Product
Table 119. Yunnan Hande Recent Developments/Updates
Table 120. Hainan Yew Pharm Corporation Information
Table 121. Hainan Yew Pharm Description and Business Overview
Table 122. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 123. Hainan Yew Pharm Paclitaxel Product
Table 124. Hainan Yew Pharm Recent Developments/Updates
Table 125. Jiangsu Yew Biotechnology Corporation Information
Table 126. Jiangsu Yew Biotechnology Description and Business Overview
Table 127. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 128. Jiangsu Yew Biotechnology Paclitaxel Product
Table 129. Jiangsu Yew Biotechnology Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Paclitaxel Distributors List
Table 133. Paclitaxel Customers List
Table 134. Paclitaxel Market Trends
Table 135. Paclitaxel Market Drivers
Table 136. Paclitaxel Market Challenges
Table 137. Paclitaxel Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Paclitaxel
Figure 2. Global Paclitaxel Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Paclitaxel Market Share by Type in 2022 & 2029
Figure 4. Natural Paclitaxel API Product Picture
Figure 5. Semi-synthetic Paclitaxel API Product Picture
Figure 6. Global Paclitaxel Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Paclitaxel Market Share by Application in 2022 & 2029
Figure 8. Ovarian Cancer
Figure 9. Cervical Cancer
Figure 10. Breast Cancer
Figure 11. Others
Figure 12. Global Paclitaxel Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Paclitaxel Market Size (2018-2029) & (US$ Million)
Figure 14. Global Paclitaxel Sales (2018-2029) & (Kg)
Figure 15. Global Paclitaxel Average Price (USD/Kg) & (2018-2029)
Figure 16. Paclitaxel Report Years Considered
Figure 17. Paclitaxel Sales Share by Manufacturers in 2022
Figure 18. Global Paclitaxel Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Paclitaxel Players: Market Share by Revenue in 2022
Figure 20. Paclitaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Paclitaxel Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Paclitaxel Sales Market Share by Country (2018-2029)
Figure 23. North America Paclitaxel Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Paclitaxel Sales Market Share by Country (2018-2029)
Figure 27. Europe Paclitaxel Revenue Market Share by Country (2018-2029)
Figure 28. Germany Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Paclitaxel Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Paclitaxel Revenue Market Share by Region (2018-2029)
Figure 35. China Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Paclitaxel Sales Market Share by Country (2018-2029)
Figure 46. Latin America Paclitaxel Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Paclitaxel Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Paclitaxel Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Paclitaxel Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Paclitaxel by Type (2018-2029)
Figure 56. Global Revenue Market Share of Paclitaxel by Type (2018-2029)
Figure 57. Global Paclitaxel Price (USD/Kg) by Type (2018-2029)
Figure 58. Global Sales Market Share of Paclitaxel by Application (2018-2029)
Figure 59. Global Revenue Market Share of Paclitaxel by Application (2018-2029)
Figure 60. Global Paclitaxel Price (USD/Kg) by Application (2018-2029)
Figure 61. Paclitaxel Value Chain
Figure 62. Paclitaxel Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs